Mesoblast Limited (ASX:MSB)
2.450
-0.040 (-1.61%)
Jul 30, 2025, 4:10 PM AEST
Mesoblast Employees
Mesoblast had 73 employees as of June 30, 2024. The number of employees decreased by 10 or -12.05% compared to the previous year.
Employees
73
Change (1Y)
-10
Growth (1Y)
-12.05%
Revenue / Employee
125.51K AUD
Profits / Employee
-2.29M AUD
Market Cap
3.19B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 73 | -10 | -12.05% |
Jun 30, 2023 | 83 | 6 | 7.79% |
Jun 30, 2022 | 77 | -6 | -7.23% |
Jun 30, 2021 | 83 | -19 | -18.63% |
Jun 30, 2020 | 102 | 19 | 22.89% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 32,698 |
Cochlear | 5,097 |
Sonic Healthcare | 42,000 |
Ramsay Health Care | 90,000 |
Telix Pharmaceuticals | 234 |
Ansell | 15,000 |
Regis Healthcare | 11,000 |
Neuren Pharmaceuticals | 8 |
Mesoblast News
- 12 days ago - Mesoblast shares soar 35pc on strong cell therapy sales data - The Australian Financial Review
- 12 days ago - Successful Commercial Launch of Ryoncil® - Benzinga
- 12 days ago - Successful Commercial Launch of Ryoncil® - GlobeNewsWire
- 12 days ago - ASX 200 LIVE: ASX 200 at record; Mesoblast soars 30pc on sales boost - The Australian Financial Review
- 22 days ago - Mesoblast: A Cautionary Hold On Regenerative Medicine's Risky Edge (Upgrade) - Seeking Alpha
- 4 weeks ago - Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday - Benzinga
- 4 weeks ago - Mesoblast, FDA agree on marketing application for cell therapy - Seeking Alpha
- 4 weeks ago - Mesoblast Targets Accelerated FDA Approval For Heart Failure Drug Revascor - Benzinga